Micron Just Crossed $1,000 — the Memory-Shortage Thesis From June Just Paid Off

Micron crossed the $1,000 threshold for the first time on August 17, 2026, closing near $1,011. The stock is up roughly 17 percent over the past seven days and about 19 percent over the past thirty days, and Wall Street followed the move by raising the street-high price target to $2,200. For anyone who read the June posts on this blog, the number should look familiar: the memory-shortage thesis — that HBM demand would outrun supply and re-rate Micron out of its commodity-memory history — is the exact call that is paying off now.

The driver is not a rumor or a one-off order. Micron's HBM4 is in volume production ahead of schedule, its entire 2026 HBM capacity is sold out, and the company has reported record results on the back of it — $23.9 billion in Q2 revenue at a 74.4 percent gross margin, with a Q3 guide of $33.5 billion. When a memory maker sells out a year of capacity in advance, pricing power follows, and the stock stops trading like a cyclical and starts trading like a foundry with a queue. That is the re-rating this blog flagged in June, and $1,000 is the milestone that makes it undeniable.

What the $1,000 crossing actually means

Three things changed when Micron crossed four figures. First, the psychological barrier is gone: $1,000 is where a stock stops being a "high flyer" and starts being priced as a structural winner, which tends to pull in a broader pool of institutional buyers. Second, the analyst targets followed — the street-high number moved to $2,200, roughly double the price the stock just crossed, which anchors a new narrative band for the AI memory trade. Third, the move broadened the hardware complex: when the memory leader surges, the whole semiconductor supply chain — the names covered in the July SOX bear-market post — tends to drag higher with it.

None of that is a reason to chase the stock. A 17 percent week on top of a 19 percent month is exactly the kind of move that position-sizing rules exist for. The question is not whether Micron is a good company — it clearly is, and the thesis has been right — it is whether your position in it still matches your risk rules after the run-up. A stock that doubles its target and keeps climbing is the single most common way retail portfolios drift into a concentration they did not plan for.

How to audit your Micron exposure

The first step is knowing what you actually hold, which means seeing every brokerage in one place instead of logging into each one separately and adding up the same ticker by hand. That is exactly what InvestSheet removes: it syncs positions from Robinhood, Fidelity, Schwab, and 35+ other brokerages into a single Google Sheet, so your Micron exposure — direct shares plus the memory weight inside any semiconductor or AI fund you hold — shows up next to everything else with live formulas:

With the numbers in one place, run the same checks the position-sizing and stop-loss posts walk through. Has Micron drifted past your single-name cap after the run-up? Are you still comfortable with the position size if the stock gives back the recent spike? A $2,200 target is an opinion, not a promise — the June thesis was right about the shortage, but the portfolio that survives is the one that sized for the possibility that the thesis was wrong too.

The bigger picture: the AI memory trade is now the clearest proof that the AI infrastructure story is real, not a narrative. Microsoft's $30B Azure run-rate, the NVDA-SpaceX deal, and now Micron crossing $1,000 with sold-out HBM are the same underlying demand showing up in three different ledgers. The question every investor with AI exposure should be asking is whether their portfolio reflects the full position — across direct holdings, funds, and every brokerage — or whether the run-up simply left the concentration unmanaged.

Frequently asked questions